Carrying over the “bect” in its logo as a nod to Becton, Dickinson and Company, embecta will maintain international manufacturing sites that previously produced around 8 billion injection devices ...
BD’s new company will have the freedom to expand its portfolio of tools and technologies for the chronic care of diabetes. (BD) () After nearly a century spent building out its portfolio of insulin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results